Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10058 |
| Vaccine Name | TAK-019 |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Protein subunit |
| Vaccine Status | Approved |
| Manufacturer | Takeda Pharmaceutical Company Limited |
| Year of Manufacturing | 2021 |
| Manufacturing Country | USA |
| Age | 20 years and above |
| Dosage | 2 doses 21 days apart |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | US FDA, Japan MHLW |
| Collaborating Organisation | NA |
| Other Countries | Indonesia, Philippines, Japan |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT05299359 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT05299359 |
| Additional Links | NA |